• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Vital Images inks deal with Toshiba

Article

Medical imaging software firm Vital Images has entered into a marketing and distribution agreement with the medical systems

Medical imaging software firm Vital Images has entered into a marketing and distribution agreement with the medical systems unit of Toshiba, headquartered in Tochigi, Japan. The deal calls for Toshiba to offer Vital Images' Vitrea 2 software through its subsidiaries and distributors in more than 50 countries in North and South America, Europe, the Middle East, Africa, Australia, and Asia, excepting Japan. The agreement also supersedes and extends Vital Images' current marketing and distribution arrangement with Toshiba America Medical Systems (TAMS), Toshiba's U.S. subsidiary. Since October 2000, TAMS has offered Vitrea 2 systems as the 3D medical imaging product of choice to customers purchasing Aquilion CT scanners. Initially, TAMS purchased the hardware platform as well as software and services.

The new agreement covers only higher margin software and services and includes a minimum worldwide revenue commitment of $4 million. The agreement is retroactive to Oct. 1, 2001, and will be effective through Sept. 30, 2002. It can be extended by mutual consent of Vital Images and Toshiba.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.